https://www.selleckchem.com/products/blu-554.html
should be taken into account when individualizing TIR targets, regardless of age or the type of treatment used. Since the first case of dextranomer/hyaluronic acid (Dx/HA) implant calcification in 2008, concern about the long-term sequelae of Dx/HA injection has been growing. According to previous reports, the incidence of Dx/HA calcification 4 years after injection would be around 2%. The primary aim was to estimate the incidence of Dx/HA implant calcification after endoscopic treatment of vesicoureteral reflux in pediatric patients. S
Beğen
Yorum Yap
Paylaş
